The PE-portfolio CMO handbook.
A field-guide for PE-portfolio CMOs running marketing operations across multi-brand healthcare networks, multi-brand FMCG portfolios, or multi-brand industrial-services consolidations. Drawn from running Partnered Health (60+ clinics), Avant Portfolio (3 sub-brands), Gorilla Glue + O'Keeffe's (multi-brand FMCG).
Five operational priorities for the first 90 days
1. Establish brand-level cost transparency
Per-brand invoicing must be consistent across the agency relationship. If your agency is invoicing in mixed buckets (e.g. "creative services" without brand attribution), get them to disaggregate. PE finance functions reconcile against budget at brand level, not portfolio level. Per-brand "Digital Agency Fee" lines on every invoice, like we run for Gorilla Glue + O'Keeffe's, is the operational standard.
2. Move to one senior strategist across the portfolio
If you have 3-6 different senior strategists from one agency for 3-6 sub-brands, performance optimisation suffers. The senior strategist who sees the whole portfolio side-by-side surfaces cross-brand patterns the per-brand seniors miss. Move to one senior strategist, and protect their time across the portfolio.
3. Get to BigQuery + Looker portfolio reporting
Platform-native dashboards (Google Ads + Meta + GA4) per brand don't roll up to portfolio view without a data layer. BigQuery + Looker as the consolidation layer, refreshed daily, queryable via NL2SQL, is the reporting infrastructure that makes the portfolio CEO's monthly review actually data-driven. Without it, you're stitching screenshots in a deck.
4. Ad spend at cost, audit-able
Audit your current agency's media markup. Every healthcare PE deal we see has at least 10-15% hidden ad-spend markup somewhere in the agency relationship, typically inside CPM uplift, undisclosed media-buyer commissions, or tools-rebilling. The audit is uncomfortable; it's also where the cleanest margin recovery sits. Move to ad spend at cost.
5. Document the AHPRA / compliance review pipeline
For PE-backed healthcare portfolios specifically, AHPRA's enforcement attention has intensified through 2026. Documented review pipelines, named reviewer attribution, provenance metadata on creative outputs are now table-stakes. Agencies without documented governance are accumulating regulatory exposure quietly. Get the policy in writing, with named accountable reviewers, before the inquiry comes.
Three operational decisions for the first 6 months
A. Single agency vs panel
Single agency with multi-brand engagement (our model) vs panel of specialists per brand. Single-agency wins on portfolio coherence + cost transparency + operational tempo. Panel wins on theoretical specialist depth but loses on coordination overhead. For mid-market PE portfolios (3-10 sub-brands), single-agency dominates.
B. Centralised vs distributed marketing operations
Centralised marketing ops at portfolio level + brand-level marketing leads, the standard model, works well when the agency relationship is multi-brand single-team. Where the agency relationship is panel-of-specialists, distributed ops at brand level performs better, with portfolio CMO as orchestrator. The model has to fit the agency structure.
C. AI Automation timing
Most PE-backed portfolios should run an AI Automation Audit before scaling AI investment. The portfolio-CFO economics depend on per-brand CAC reduction + per-brand content production efficiency. The audit produces a working pilot you can extrapolate from, not a deck you can't validate.
Read more:
Running a PE-portfolio CMO function?
Forty-five-minute call. We'll review your portfolio's marketing operating model and quote a multi-brand engagement that fits.
Book a Discovery